Brief Skills for Safer Living (Brief-SfSL)
NCT Number: NCT06571916
Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Phases: NA
Conditions: Suicide Prevention|Suicide|Suicide and Self-harm
Interventions: BEHAVIORAL: Brief-SfSL
Sponsor: Unity Health Toronto
Sex: ALL
Age: ADULT, OLDER_ADULT
Enrollment: 150
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2025-01-02
Completion Date: 2028-12-31
Locations: St. Michael's Hospital, Toronto, Ontario, M5B 1M8, Canada

Summary:
The goal of this project is to assess the efficacy of Brief-Skills for Safer Living (Brief-SfSL) in a randomized control trial. The investigators will be testing 150 participants Canada-wide, half of which will be randomized to receive Brief-SfSL (B-TAU) and the other half will be randomized to receive Brief-SfSL after a 3 month waitlist (WL-TAU). The main questions this study seeks to answer are:

* Is B-TAU more efficacious than WL-TAU for reducing suicidal thoughts at 3 months?
* Is B-TAU more efficacious than WL-TAU at 3 months for reducing depression severity, anxiety, as well as improving quality of life?
* Are adverse events equivalent between B-TAU and WL-TAU at 3 months?

Primary Outcome Measures: Change in suicidal ideation using Beck Scale for Suicide Ideation, Beck Scale for Suicide Ideation is a 21-item self-report scale that quantifies suicidal ideation. Items are scored 0 to 2 and yield a total score ranging from 0 to 38. Higher scores reflect greater severity of suicidal ideation., From baseline to 3 months post-intervention
Secondary Outcome Measures: Change in anxiety symptoms using the Generalized Anxiety Disorder 7-item scale (GAD-7), The GAD-7 is a brief 7-item self-report scale measuring anxiety symptoms. Total scores range from 0 to 21, with higher scores reflecting more severe anxiety., From baseline to 3 months post-intervention|Change in quality of life using the Quality of Life Scale (QoLS), The QoLS is a validated 15-item scale. Scores can range from 16 to 112, with higher scores reflecting a higher quality of life., From baseline to 3 months post-intervention|Change in depression symptoms using the Quick Inventory of Depressive Symptoms 16-item scale (QIDS)., The QIDS is a 16-item validated depression scale. Total scores range from 0-27, with higher scores reflecting more severe depression., From baseline to 3 months post-intervention|Participant safety as measured by adverse events, Participants will be asked to report any adverse events experienced at each visit. Investigators will measure if there are any differences in the number, severity or relatedness between group to ensure the intervention is safe., Through study completion, an average of 3 months|Suicide severity differences between groups as measured by the Columbia Suicide Severity Rating Scale (C-SSRS), The C-SSRS is a semi-structured clinical interview to assess suicidal ideation, attempt history and risk (lifetime, current, and since last visit). Investigators will be analyzing if there is any difference in C-SSRS severity between groups to ensure safety of the intervention., Through study completion, an average of 3 months